Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
The Journal of Rheumatology|November 1, 1996
Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trialA McEntegart, D Porter, H A Capell, et al.Rheumatology (Oxford, England)|June 27, 2001
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritisA McEntegart, H A Capell, D Creran, et al.Annals of the Rheumatic Diseases|July 1, 1997
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritisA McEntegart, E Morrison, H A Capell, et al.Annals of the Rheumatic Diseases|July 7, 2007
A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in GlasgowG McKellar, E Morrison, A McEntegart, et al.British Journal of Rheumatology|November 1, 1995
Clinical efficacy of sulphasalazine--a reviewH A CapellThe Journal of Rheumatology. Supplement|June 21, 2001
Disease modifying antirheumatic drugs: longterm safety issuesH A CapellAnnals of the Rheumatic Diseases|February 1, 1985
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?T Pullar, H A CapellBritish Journal of Rheumatology|August 1, 1986
Selection of suitable patients for second-line therapy in rheumatoid arthritisT Pullar, H A CapellBritish Journal of Rheumatology|February 1, 1984
Sulphasalazine: a 'new' antirheumatic drugT Pullar, H A CapellClinical Rheumatology|March 1, 1984
Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalateD Lewis, H A CapellPageof 12